Stock Analysis
Privia Health Group, Inc. (PRVA) Stock Analysis
Privia Health Group, Inc. (PRVA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Privia Health Group, Inc. (PRVA) currently has an AIQ Score of 40/100, indicating a neutral setup. Risk is the strongest factor at 72/100. Momentum is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
PRVA at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $20.42 |
| AIQ Score | 40/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $2.6B |
| P/E Ratio | 98.29 |
| Forward P/E | — |
| EPS | $0.07 |
| Revenue TTM | $632.63M |
| Dividend Yield | 0.00% |
| Beta | 0.9 |
| Volume | 925.3K |
| 52-week range | $19.53-$28.82 |
| RSI 14 | 31.18 |
| 50-Day SMA | $23.49 |
| 200-Day SMA | $23.19 |
| Analyst Price Target | $27.33 |
| Next Earnings | Nov 5, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
PRVA
OverviewPRVA Stock Analysis Summary
Privia Health Group, Inc. (PRVA) currently has an AIQ Score of 40/100, indicating a neutral setup. Risk resilience is the strongest factor at 72/100. Momentum is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, PRVA has AIQ Score of 40/100 with Risk resilience base of 72/100 and fading Momentum at 26/100. Wait for component alignment before adding exposure.
Risk resilience (72/100) leads while Momentum (26/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.25% stock move · PRVA classified in Medical - Healthcare Information Services.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is PRVA Bullish or Bearish Right Now?
PRVA currently has a neutral overall setup. Risk Resilience is the strongest factor at 72/100, while Momentum is weakest at 26/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 72/100.
- - Analyst target implies +33.84% upside from the latest quote.
- - Value is the current constraint at 42/100.
- - Momentum is weak at 26/100.
- - Price is -11.95% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (32 vs 8).
Current Consensus
PRVA's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 5 neutral, and 32 sell votes. PRVA's 14-day RSI is 31.18, which places the stock in a weaker momentum range. PRVA's beta is 0.9, indicating market sensitivity broadly in line with the market.
What Changed in PRVA?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the PRVA Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
PRVA Decision Framework
Public evidence layers, setup checks, and risk context for Privia Health Group, Inc..
Privia Health Group, Inc. (PRVA) Stock Analysis
Privia Health Group, Inc. has an AIQ Score of 40/100 in a Neutral regime. Risk is strongest at 72/100. Beta is 0.9, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | PRVA is in a Neutral AIQ regime with score 40/100. |
| Signal Conflict | The primary conflict is that risk leads at 72/100 while momentum lags at 26/100. |
| Factor Evidence | Momentum 26/100 · Value 42/100 · Quality 33/100 · Risk 72/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 72/100.
Momentum is 26/100 and RSI (14) is 31.2.
PRVA is in a Neutral regime at 40/100.
Risk factor is 72/100 with beta 0.9 and annual volatility 31.88%.
Current conflict: risk leads at 72/100 while momentum lags at 26/100.
PRVA Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
PRVA Fundamentals
PRVA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
PRVA Technical Analysis
PRVA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
PRVA Stock Catalysts
Track PRVA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
PRVA Dividend Analysis
PRVA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
PRVA Financial Data
PRVA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
PRVA Risk Analysis
PRVA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
PRVA Stock News
PRVA stock news, market tone, recent headlines, and catalyst context.
PRVA vs Healthcare Services / Managed Care Peers
Current peer cohort: PRVA · TDOC · UHS · UNH · ALHC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| PRVA Current stock | 40/100 | 42/100 | 26/100 | 72/100 | -0.3 | 31.88% | Current |
| TDOC Teladoc Health | 47/100 | 65/100 | 35/100 | 27/100 | -0.03 | 64.39% | PRVA vs TDOC |
| UHS Universal Health Services | 64/100 | 73/100 | 50/100 | 60/100 | -0.15 | 32.33% | PRVA vs UHS |
| UNH UnitedHealth Group | 50/100 | 59/100 | 40/100 | 58/100 | 0.32 | 34.65% | PRVA vs UNH |
| ALHC Alignment Healthcare | 40/100 | 42/100 | 33/100 | 53/100 | -0.18 | 61.85% | PRVA vs ALHC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching PRVA
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for PRVA
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
PRVA Stock FAQ
What is PRVA stock price today?
Privia Health Group, Inc.'s current stock price is $20.42. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is PRVA bullish or bearish right now?
PRVA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is PRVA's market cap?
PRVA's market cap is $2.6B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is PRVA's current P/E ratio?
PRVA's current P/E ratio is 98.29 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is PRVA's RSI?
PRVA's 14-day RSI is 31.18 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is PRVA above its 50-day and 200-day moving averages?
PRVA is -13.07% from its 50-day SMA and -11.95% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is PRVA's next earnings date?
PRVA's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does PRVA pay a dividend?
PRVA's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.